BETHESDA, Md., Sept. 9, 2013 /PRNewswire-USNewswire/ -- Today, representatives from the U.S. Food and Drug Administration (FDA), industry and the diabetes advocacy community will convene at a Diabetes Technology Society meeting in Bethesda, Md., to discuss possible solutions for verifying the accuracy of self-monitoring blood glucose (SMBG) systems. The following statement can be attributed to Larry Ellingson, spokesperson for the National Diabetes Volunteer Leadership Council (NDVLC) and past chair of the American Diabetes Association board (2005):
"On behalf of the NDVLC and the 25.8 million Americans living with diabetes, we applaud the efforts of the Diabetes Technology Society to examine the very serious and potentially life-threatening issue of inaccurate SMBG systems. Patients with diabetes rely on these systems to guide the decisions they make multiple times a day about their disease management, and it is crucial that the information is accurate to avoid putting their health at risk.
We look forward to hearing from the FDA today on ways they plan to enforce accuracy standards equally among all SMBG manufacturers. It is simply unacceptable that up to 45 percent of the systems marketed globally to patients with diabetes do not meet the minimum accuracy requirements post-approval and that some manufacturers have failed to provide the FDA with the requisite medical device reporting (MDR) of adverse events.
The NDVLC encourages the FDA to closely examine and enforce the approval and testing processes for these devices to create a safer environment for patients living with diabetes. The FDA should use their existing authority to ensure the health and safety of patients with diabetes while considering any new approval standards, validation, and continuous monitoring of SMBG systems post-clearan
SOURCE National Diabetes Volunteer Leadership Council
Copyright©2012 PR Newswire.
All rights reserved
Page: 1 2
Related medicine technology :
1. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
2. WIKA Process Solutions, Deer Park, Texas Acquires Gayesco International.
3. The Partnership at Drugfree.org Comments on National Survey on Drug Use and Health, Statement of Steve Pasierb, President and CEO
4. PAREXEL International To Present At Robert Baird Healthcare Conference And Raymond James North American Equities Conference
5. Parents and Harm Reduction Advocates from Southern California Gather in Los Angeles for the 13th Annual International Overdose Awareness Day on August 31
6. National coordinated health care and health IT transformation event will be hosted by OCHIN, Inc., the Oregon Medical Association, and Oregon Health Network: The cHealth Innovation Symposium
7. BioLineRx to Present at 15th International Celiac Disease Symposium
8. Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
9. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
10. Larkin Community Hospital Hosts International Dental Teaching Symposium
11. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate